clebopride has been researched along with Supranuclear Palsy, Progressive in 1 studies
clebopride: antidopaminergic; RN given refers to parent cpd; structure
Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campdelacreu, J | 1 |
| Kumru, H | 1 |
| Tolosa, E | 1 |
| Valls-Solé, J | 1 |
| Benabarre, A | 1 |
1 other study available for clebopride and Supranuclear Palsy, Progressive
| Article | Year |
|---|---|
Progressive supranuclear palsy syndrome induced by clebopride.
Topics: Antiemetics; Benzamides; Female; Humans; Middle Aged; Supranuclear Palsy, Progressive | 2004 |